Compare Aurora Cannabis Inc (ACB) vs ProShares Bitcoin ETF (BITO) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

BITO trades at $8.64, up 3.6% over 24 hours amid a mixed technical picture with a bullish overall signal but bearish moving averages. Recent dividend distributions of $0.01-$0.02 per share provide modest income, though financial ratios like P/E and P/S are unavailable. News sentiment reflects caution as the fund faces scrutiny over performance gaps versus Bitcoin and fee structures.

Outlook remains clouded by volatile crypto markets and investor skepticism; risks include fee drag and regulatory uncertainty. Analysts highlight distribution cuts and correlation shifts, suggesting limited near-term catalysts. Investors should weigh income against potential capital erosion in a challenging environment.